Tuesday, Jan 25, 2022 | Last Update : 02:09 AM IST

Hyderabad Covid vaccine

Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response

Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India

05 Oct 2020 2:02 PM

ADVERTISEMENT
ADVERTISEMENT